Tumor-Infiltrating CD1a+ DCs and CD8+/FoxP3+ Ratios Served as Predictors for Clinical Outcomes in Tongue Squamous Cell Carcinoma Patients

  • Yan-Hong Ni
  • Xiao-xin Zhang
  • Zhan-yi Lu
  • Xiao-Feng Huang
  • Zhi-Yong Wang
  • Yan Yang
  • Ying-chun Dong
  • Yue Jing
  • Yuxian Song
  • Ya-Yi Hou
  • Zi-chun Hua
  • Qin-Gang Hu
Original Article


Tumor-infiltrating immune cells engage in an extensive crosstalk with tumors and act as two-edged swords by inhibiting or promoting cancer growth. Therefore, identifying the density and prognostic values of tumor-infiltrating immune cells will provide valuable tips for cancer treatments. In this study, we identified the density of tumor inflammatory infiltrates and the number of tumor-infiltrating immune cells, including CD3+, CD4+, CD8+, FoxP3+ T cells and CD1a+ dendritic cells (DCs) in 153 tongue squamous cell carcinomas (TSCC). High inflammatory cell infiltration was associated with better overall survival (OS) and disease free survival (DFS). Moreover, the number of CD3+, CD4+, FoxP3+ and CD1a+ cells were associated with tumor differentiation (P<0.001) and the number of FoxP3+, CD1a+ cells and CD8+/FoxP3+ ratios were also associated with tumor stage (P<0.01, P<0.01, P<0.05). In addition, patients with higher CD1a+ DCs had better OS and increased CD8+/FoxP3+ ratios were associated with improved OS and DFS (P = 0.037; P = 0.047; P = 0.033). In conclusion, our results indicated that tumor-infiltrating CD1a+ DCs and CD8+/FoxP3+ ratios were associated with favorable clinical outcomes but not independent prognostic factors for TSCC patients.


Tongue squamous cell carcinoma Tumor infiltrating immune cell Clinical outcome Diagnostic value 



This work was supported by the National Natural Science Foundation of China (No. 81772880, 81702680), Nanjing Medical Science and Technique Development Foundation (No. YKK16164, QRX17083), Jiangsu Provincial Key Medical Discipline (since 2017), Nanjing Municipal Key Medical Laboratory Constructional Project Funding (Since 2016), Center of Nanjing Clinical Medicine of tumor project (Since 2014).

Compliance with Ethical Standards

Conflict of Interest

None declared.

Supplementary material

12253_2019_701_MOESM1_ESM.docx (1.7 mb)
ESM 1 (DOCX 1700 kb)


  1. 1.
    Bello IO, Soini Y, Salo T (2010) Prognostic evaluation of oral tongue cancer: means, markers and perspectives (I). Oral Oncol 46(9):630–635. CrossRefPubMedGoogle Scholar
  2. 2.
    Schreiber RD, Old LJ, Smyth MJ (2011) Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science (New York, NY) 331(6024):1565–1570. CrossRefGoogle Scholar
  3. 3.
    Mao Y, Qu Q, Chen X, Huang O, Wu J, Shen K (2016) The prognostic value of tumor-infiltrating lymphocytes in breast Cancer: a systematic review and meta-analysis. PLoS One 11(4):e0152500. CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Hwang WT, Adams SF, Tahirovic E, Hagemann IS, Coukos G (2012) Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis. Gynecol Oncol 124(2):192–198. CrossRefPubMedGoogle Scholar
  5. 5.
    Fang J, Li X, Ma D, Liu X, Chen Y, Wang Y, Lui VWY, Xia J, Cheng B, Wang Z (2017) Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma. BMC Cancer 17(1):375. CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Geng Y, Shao Y, He W, Hu W, Xu Y, Chen J, Wu C, Jiang J (2015) Prognostic role of tumor-infiltrating lymphocytes in lung Cancer: a meta-analysis. Cell Physiol Biochem 37(4):1560–1571. CrossRefPubMedGoogle Scholar
  7. 7.
    Barnes TA, Amir E (2017) HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer. Br J Cancer 117(4):451–460. CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Liotta F, Gacci M, Frosali F, Querci V, Vittori G, Lapini A, Santarlasci V, Serni S, Cosmi L, Maggi L, Angeli R, Mazzinghi B, Romagnani P, Maggi E, Carini M, Romagnani S, Annunziato F (2011) Frequency of regulatory T cells in peripheral blood and in tumour-infiltrating lymphocytes correlates with poor prognosis in renal cell carcinoma. BJU Int 107(9):1500–1506. CrossRefPubMedGoogle Scholar
  9. 9.
    Ugel S, De Sanctis F, Mandruzzato S, Bronte V (2015) Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages. J Clin Invest 125(9):3365–3376. CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Wallis SP, Stafford ND, Greenman J (2015) Clinical relevance of immune parameters in the tumor microenvironment of head and neck cancers. Head Neck 37(3):449–459. CrossRefPubMedGoogle Scholar
  11. 11.
    Park K, Cho KJ, Lee M, Yoon DH, Kim SB (2013) Importance of FOXP3 in prognosis and its relationship with p16 in tonsillar squamous cell carcinoma. Anticancer Res 33(12):5667–5673PubMedGoogle Scholar
  12. 12.
    Wolf GT, Chepeha DB, Bellile E, Nguyen A, Thomas D, McHugh J University of Michigan H, neck SP (2015) tumor infiltrating lymphocytes (TIL) and prognosis in oral cavity squamous carcinoma: a preliminary study. Oral Oncol 51(1):90–95. CrossRefGoogle Scholar
  13. 13.
    de Ruiter EJ, Ooft ML, Devriese LA, Willems SM (2017) The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: a systematic review and meta-analysis. Oncoimmunology 6(11):e1356148. CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Nguyen N, Bellile E, Thomas D, McHugh J, Rozek L, Virani S, Peterson L, Carey TE, Walline H, Moyer J, Spector M, Perim D, Prince M, McLean S, Bradford CR, Taylor JM, Wolf GT, Head NSPI (2016) Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma. Head Neck 38(7):1074–1084. CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Wansom D, Light E, Thomas D, Worden F, Prince M, Urba S, Chepeha D, Kumar B, Cordell K, Eisbruch A, Taylor J, Moyer J, Bradford C, D'Silva N, Carey T, McHugh J, Wolf G, Program UMHNS (2012) Infiltrating lymphocytes and human papillomavirus-16--associated oropharyngeal cancer. Laryngoscope 122(1):121–127. CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Sun DS, Zhao MQ, Xia M, Li L, Jiang YH (2012) The correlation between tumor-infiltrating Foxp3+ regulatory T cells and cyclooxygenase-2 expression and their association with recurrence in resected head and neck cancers. Med Oncol 29(2):707–713. CrossRefPubMedGoogle Scholar
  17. 17.
    Matsutani S, Shibutani M, Maeda K, Nagahara H, Fukuoka T, Iseki Y, Kashiwagi S, Tanaka H, Hirakawa K, Ohira M (2018) Tumor-infiltrating immune cells in H&E-stained sections of colorectal Cancer tissue as a reasonable immunological biomarker. Anticancer Res 38(12):6721–6727. CrossRefPubMedGoogle Scholar
  18. 18.
    Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, Wienert S, Van den Eynden G, Baehner FL, Penault-Llorca F, Perez EA, Thompson EA, Symmans WF, Richardson AL, Brock J, Criscitiello C, Bailey H, Ignatiadis M, Floris G, Sparano J, Kos Z, Nielsen T, Rimm DL, Allison KH, Reis-Filho JS, Loibl S, Sotiriou C, Viale G, Badve S, Adams S, Willard-Gallo K, Loi S, International TWG (2015) The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an international TILs working group 2014. Ann Oncol 26 (2):259–271. doi: CrossRefGoogle Scholar
  19. 19.
    Kushwah R, Hu J (2011) Role of dendritic cells in the induction of regulatory T cells. Cell Biosci 1(1):20. CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Ng JH, Iyer NG, Tan MH, Edgren G (2017) Changing epidemiology of oral squamous cell carcinoma of the tongue: a global study. Head Neck 39(2):297–304. CrossRefPubMedGoogle Scholar
  21. 21.
    Almangush A, Bello IO, Coletta RD, Makitie AA, Makinen LK, Kauppila JH, Pukkila M, Hagstrom J, Laranne J, Soini Y, Kosma VM, Koivunen P, Kelner N, Kowalski LP, Grenman R, Leivo I, Laara E, Salo T (2015) For early-stage oral tongue cancer, depth of invasion and worst pattern of invasion are the strongest pathological predictors for locoregional recurrence and mortality. Virchows Arch 467(1):39–46. CrossRefPubMedGoogle Scholar
  22. 22.
    Sopka DM, Li T, Lango MN, Mehra R, Liu JC, Burtness B, Flieder DB, Ridge JA, Galloway TJ (2013) Dysplasia at the margin? Investigating the case for subsequent therapy in 'low-risk' squamous cell carcinoma of the oral tongue. Oral Oncol 49(11):1083–1087. CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Lundqvist L, Stenlund H, Laurell G, Nylander K (2012) The importance of stromal inflammation in squamous cell carcinoma of the tongue. J Oral Pathol Med 41(5):379–383. CrossRefPubMedGoogle Scholar
  24. 24.
    Chatzistamou I, Rodriguez J, Jouffroy T, Girod A, Point D, Sklavounou A, Kittas C, Sastre-Garau X, Klijanienko J (2010) Prognostic significance of tumor shape and stromal chronic inflammatory infiltration in squamous cell carcinomas of the oral tongue. J Oral Pathol Med 39(9):667–671. CrossRefPubMedGoogle Scholar
  25. 25.
    Rodrigues PC, Miguel MC, Bagordakis E, Fonseca FP, de Aquino SN, Santos-Silva AR, Lopes MA, Graner E, Salo T, Kowalski LP, Coletta RD (2014) Clinicopathological prognostic factors of oral tongue squamous cell carcinoma: a retrospective study of 202 cases. Int J Oral Maxillofac Surg 43(7):795–801. CrossRefPubMedGoogle Scholar
  26. 26.
    Almangush A, Bello IO, Keski-Santti H, Makinen LK, Kauppila JH, Pukkila M, Hagstrom J, Laranne J, Tommola S, Nieminen O, Soini Y, Kosma VM, Koivunen P, Grenman R, Leivo I, Salo T (2014) Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer. Head Neck 36(6):811–818. CrossRefPubMedGoogle Scholar
  27. 27.
    Gomes JO, de Vasconcelos Carvalho M, Fonseca FP, Gondak RO, Lopes MA, Vargas PA (2016) CD1a+ and CD83+ Langerhans cells are reduced in lower lip squamous cell carcinoma. J Oral Pathol Med 45(6):433–439. CrossRefPubMedGoogle Scholar
  28. 28.
    Yilmaz T, Gedikoglu G, Celik A, Onerci M, Turan E (2005) Prognostic significance of Langerhans cell infiltration in cancer of the larynx. Otolaryngol Head Neck Surg 132(2):309–316. CrossRefPubMedGoogle Scholar
  29. 29.
    Jardim JF, Gondak R, Galvis MM, Pinto CAL, Kowalski LP (2018) A decreased peritumoral CD1a+ cell number predicts a worse prognosis in oral squamous cell carcinoma. Histopathology 72(6):905–913. CrossRefPubMedGoogle Scholar
  30. 30.
    Balermpas P, Michel Y, Wagenblast J, Seitz O, Weiss C, Rodel F, Rodel C, Fokas E (2014) Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer. Br J Cancer 110(2):501–509. CrossRefPubMedGoogle Scholar
  31. 31.
    Badoual C, Hans S, Rodriguez J, Peyrard S, Klein C, Agueznay Nel H, Mosseri V, Laccourreye O, Bruneval P, Fridman WH, Brasnu DF, Tartour E (2006) Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Clin Cancer Res 12(2):465–472. CrossRefPubMedGoogle Scholar
  32. 32.
    Watanabe Y, Katou F, Ohtani H, Nakayama T, Yoshie O, Hashimoto K (2010) Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109(5):744–752. CrossRefPubMedGoogle Scholar
  33. 33.
    Chen WY, Wu CT, Wang CW, Lan KH, Liang HK, Huang BS, Chang YL, Kuo SH, Cheng AL (2018) Prognostic significance of tumor-infiltrating lymphocytes in patients with operable tongue cancer. Radiat Oncol 13(1):157. CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Nasman A, Romanitan M, Nordfors C, Grun N, Johansson H, Hammarstedt L, Marklund L, Munck-Wikland E, Dalianis T, Ramqvist T (2012) Tumor infiltrating CD8+ and Foxp3+ lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancer. PLoS One 7(6):e38711. CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Gooden MJ, de Bock GH, Leffers N, Daemen T, Nijman HW (2011) The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer 105(1):93–103. CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Arányi Lajos Foundation 2019

Authors and Affiliations

  • Yan-Hong Ni
    • 1
    • 2
  • Xiao-xin Zhang
    • 1
  • Zhan-yi Lu
    • 2
  • Xiao-Feng Huang
    • 1
  • Zhi-Yong Wang
    • 2
  • Yan Yang
    • 1
  • Ying-chun Dong
    • 1
  • Yue Jing
    • 1
  • Yuxian Song
    • 1
  • Ya-Yi Hou
    • 1
  • Zi-chun Hua
    • 1
  • Qin-Gang Hu
    • 1
    • 2
    • 3
  1. 1.Central Laboratory, Nanjing Stomatological Hospital, Medical SchoolNanjing UniversityNanjingChina
  2. 2.Department of Oral and Maxillofacial Surgery, Nanjing Stomatological Hospital, Medical SchoolNanjing UniversityNanjingChina
  3. 3.NanjingChina

Personalised recommendations